We serve Chemical Name:5-Amino-1-naphthalenesulfonyl chloride CAS:145061-31-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Amino-1-naphthalenesulfonyl chloride
CAS.NO:145061-31-0
Synonyms:5-Amino-1-naphthalenesulfonyl chloride
Molecular Formula:C10H8ClNO2S
Molecular Weight:241.69400
HS Code:2921450090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:413ºC at 760 mmHg
Density:1.487 g/cm3
Index of Refraction:
PSA:68.54000
Exact Mass:240.99600
LogP:4.01150
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-Amino-1-naphthalenesulfonyl chloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Amino-1-naphthalenesulfonyl chloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Amino-1-naphthalenesulfonyl chloride Use and application,5-Amino-1-naphthalenesulfonyl chloride technical grade,usp/ep/jp grade.
Related News: The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. 5-Amino-1-naphthalenesulfonyl chloride manufacturer Pharmaceutical intermediates and APIs belong to the fine chemical industry. 5-Amino-1-naphthalenesulfonyl chloride supplier The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years. 5-Amino-1-naphthalenesulfonyl chloride vendor The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years. 5-Amino-1-naphthalenesulfonyl chloride factory In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.
